Raquel P Ribeiro-Romão, Otacílio C Moreira, Elvia Yaneth Osorio, Lea Cysne-Finkelstein, Adriano Gomes-Silva, Joanna G Valverde, Claude Pirmez, Alda Maria Da-Cruz, Eduardo Fonseca Pinto
文献索引:J. Microencapsul. 11(2) , 213-24, (1994)
全文:HTML全文
The golden hamster (Mesocricetus auratus) is a susceptible model to Leishmania (Viannia) spp.; however, available studies employ different infection protocols, which account for clinical and pathological presentation differences. Herein, L. (V.) braziliensis preparations were standardized to contain 10(4), 10(5), or 10(6) parasites to determine an optimal inoculum that ensured cutaneous lesions without causing a disseminated infection in hamsters. Lesion development was followed for 105 days by size measurements, and skin, draining lymph node, spleen, and sera were investigated to check parasite load, spleen visceralization, cytokine expression, histopathological changes, and anti-Leishmania IgG levels. The lesion emergence time was inversely proportional to the parasite concentration in the inocula. Animals infected by 10(4) parasites presented nodular lesions, while those infected with 10(6) parasites often exhibited ulcerated lesions. The differences in the final lesion sizes were observed between 10(4) and 10(5) inocula or 10(4) and 10(6) inocula. High IFNG expression, anti-Leishmania IgG levels, and parasite load occurred independently of the inoculum used. A mild inflammatory skin involvement was observed in animals infected with 10(4) parasites, while extensive tissue damage and parasite spleen visceralization occurred with 10(5) and 10(6) parasites. These results indicate that inocula with different concentrations of parasites generate differences in the time of lesion emergence, clinical presentation, and systemic commitment, despite high and similar IFNG expression and parasite load. This suggests that a modulation in the immune response to different parasite numbers occurs in an early phase of the infection, which could dictate the establishment and magnitude of the chronic phase of the disease. Copyright © 2014, American Society for Microbiology. All Rights Reserved.
| 结构式 | 名称/CAS号 | 分子式 | 全部文献 |
|---|---|---|---|
![]() |
对苯二甲酰氯
CAS:100-20-9 |
C8H4Cl2O2 |
|
Synthesis and evaluation of chloramphenicol homodimers: mole...
2015-01-01 [PLoS ONE 10 , e0134526, (2015)] |
|
Synthesis of polymer-type chiral stationary phases and their...
2007-02-01 [Chirality 19(2) , 129-40, (2007)] |
|
Polyamide microcapsules containing jojoba oil prepared by in...
2005-08-01 [J. Microencapsul. 22(5) , 471-86, (2005)] |
|
Study of albumin and fibrinogen membranes formed by interfac...
2010-09-01 [Biofabrication 2(3) , 035002, (2010)] |
|
Fourier transform infrared spectroscopic studies of cross-li...
1995-02-01 [J. Pharm. Sci. 84(2) , 161-5, (1995)] |
首页 |
期刊大全 |
MSDS查询 |
化工产品分类 |
生物活性化合物 |
关于我们 |
免责声明:知识产权问题请联系 service1@chemsrc.com
Copyright © 2024 ChemSrc All Rights Reserved
